Hikma Pharmaceutical reported 248M in Net Income for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
AstraZeneca AZN:LN -1652M 2202M
Bayer BAYN:GR € 85M 2420M
Fresenius FRE:GR € 413M 58M
Fresenius Medical Care FMS:US $ 273M 54.42M
Galapagos GLPG:NA € -64.61M 0.28M
Genmab GEN:DC DK 890M 584M
GlaxoSmithKline GSK:LN 1168M 227M
GRIFOLS GRF:SM € 136.88M 6.94M
H. Lundbeck A/S LUN:DC 321M 57M
Hikma Pharmaceutical HIK:LN 248M 29M
Lonza Group LONN:SW 319M 73M
Merck MRK:GR € 761M 16M
Orion ORNBV:FH € 45.5M 10.5M
Recordati REC:IM € 89.3M 27.91M